Skip to content
Banzel, Inovelon(rufinamide)
Banzel, Inovelon (rufinamide) is a small molecule pharmaceutical. Rufinamide was first approved as Inovelon on 2007-01-16. It is used to treat seizures in the USA. It has been approved in Europe to treat epilepsy.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Banzel (generic drugs available since 2016-05-16)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Rufinamide
Tradename
Company
Number
Date
Products
BANZELEisaiN-021911 RX2008-11-14
2 products, RLD, RS
BANZELEisaiN-201367 RX2011-03-03
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
banzelNew Drug Application2021-12-23
rufinamideANDA2023-03-20
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
seizuresHP_0007359D012640G40.4
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N03: Antiepileptics
— N03A: Antiepileptics
— N03AF: Carboxamide derivatives, antiepileptics
— N03AF03: Rufinamide
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lennox gastaut syndromeD065768G40.81——3—25
EpilepsyD004827EFO_0000474G40.9——1—12
SeizuresD012640G40.41—1——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52—1———1
Peripheral nerve injuriesD059348—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameRUFINAMIDE
INNrufinamide
Description
Rufinamide is a heteroarene and an aromatic amide.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
NC(=O)c1cn(Cc2c(F)cccc2F)nn1
Identifiers
PDB—
CAS-ID106308-44-5
RxCUI69036
ChEMBL IDCHEMBL1201754
ChEBI ID—
PubChem CID129228
DrugBankDB06201
UNII IDWFW942PR79 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 927 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
6,530 adverse events reported
View more details